特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

鎮痛薬の世界市場:産業動向、シェア、規模、成長率、機会、予測

Analgesics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

発行 IMARC Services Private Limited 商品コード 788395
出版日 ページ情報 英文 102 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
鎮痛薬の世界市場:産業動向、シェア、規模、成長率、機会、予測 Analgesics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: 2019年02月11日 ページ情報: 英文 102 Pages
概要

当レポートでは、世界の鎮痛薬市場について調査分析し、市場実績、地域別の市場分析、市場内訳、バリューチェーン分析、主要促進要因・課題、市場構造、主要企業、競合情勢などについて、体系的な情報を提供しています。

第1章 序文

第2章 調査範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の鎮痛薬市場

  • 市場概要
  • 市場実績
  • 市場内訳:種類別
  • 市場内訳:薬剤分類別
  • 市場内訳:投与経路別
  • 市場内訳:疼痛の種類別
  • 市場内訳:用途別
  • 市場内訳:地域別
  • 市場予測

第6章 市場内訳:種類別

  • 処方
  • OTC

第7章 市場内訳:薬剤分類別

  • オピオイド
  • NSAID
  • その他

第8章 市場内訳:投与経路別

  • 経口
  • 非経口
  • 局所
  • 経皮
  • 直腸
  • その他

第9章 市場内訳:疼痛の種類別

  • 筋骨格痛
  • 術後疼痛、外傷痛
  • がん疼痛
  • 神経障害性疼痛
  • 片頭痛
  • 陣痛
  • 線維筋痛
  • やけどの痛み
  • 歯/顔の痛み
  • 小児の痛み
  • その他

第10章 市場内訳:用途別

  • 内服鎮痛薬
  • 外用鎮痛薬

第11章 市場内訳:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第12章 世界の鎮痛薬市場:SWOT分析

第13章 世界の鎮痛薬市場:バリューチェーン分析

第14章 世界の鎮痛薬市場:ファイブフォース分析

第15章 世界の鎮痛薬市場:価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bayer AG
    • Novartis AG
    • GlaxoSmithKline PLC
    • Pfizer Inc.
    • Johnson & Johnson
    • Reckitt Benckiser (RB)
    • Endo Pharmaceuticals
    • Bristol-Myers Squibb
    • Eli Lilly and Company
    • Sanofi
図表

List of Figures

  • Figure 1: Global: Analgesics Market: Major Drivers and Challenges
  • Figure 2: Global: Analgesics Market: Sales Value (in Billion US$), 2011-2018
  • Figure 3: Global: Analgesics Market: Breakup by Type (in %), 2018
  • Figure 4: Global: Analgesics Market: Breakup by Drug Class (in %), 2018
  • Figure 5: Global: Analgesics Market: Breakup by ROA (in %), 2018
  • Figure 6: Global: Analgesics Market: Breakup by Pain Type (in %), 2018
  • Figure 7: Global: Analgesics Market: Breakup by Application (in %), 2018
  • Figure 8: Global: Analgesics Market: Breakup by Region (in %), 2018
  • Figure 9: Global: Analgesics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 10: Global: Analgesics Industry: SWOT Analysis
  • Figure 11: Global: Analgesics Industry: Value Chain Analysis
  • Figure 12: Global: Analgesics Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Analgesics (Prescription) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 14: Global: Analgesics (Prescription) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 15: Global: Analgesics (OTC) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 16: Global: Analgesics (OTC) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 17: Global: Analgesics (Opioids) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 18: Global: Analgesics (Opioids) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 19: Global: Analgesics (NSAID) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 20: Global: Analgesics (NSAID) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 21: Global: Analgesics (Others) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 22: Global: Analgesics (Others) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 23: Global: Analgesics (Oral) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 24: Global: Analgesics (Oral) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 25: Global: Analgesics (Parenteral) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 26: Global: Analgesics (Parenteral) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 27: Global: Analgesics (Topical) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 28: Global: Analgesics (Topical) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 29: Global: Analgesics (Transdermal) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 30: Global: Analgesics (Transdermal) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 31: Global: Analgesics (Rectal) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 32: Global: Analgesics (Rectal) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 33: Global: Analgesics (Musculoskeletal Pain) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 34: Global: Analgesics (Musculoskeletal Pain) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 35: Global: Analgesics (Surgical and Trauma Pain) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 36: Global: Analgesics (Surgical and Trauma Pain) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 37: Global: Analgesics (Cancer Pain) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 38: Global: Analgesics (Cancer Pain) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 39: Global: Analgesics (Neuropathic Pain) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 40: Global: Analgesics (Neuropathic Pain) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 41: Global: Analgesics (Migraine) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 42: Global: Analgesics (Migraine) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 43: Global: Analgesics (Obstetrical Pain) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 44: Global: Analgesics (Obstetrical Pain) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 45: Global: Analgesics (Fibromyalgia) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 46: Global: Analgesics (Fibromyalgia) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 47: Global: Analgesics (Pain due to Burns) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 48: Global: Analgesics (Pain due to Burns) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 49: Global: Analgesics (Dental/Facial Pain) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 50: Global: Analgesics (Dental/Facial Pain) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 51: Global: Analgesics (Pediatric Pain) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 52: Global: Analgesics (Pediatric Pain) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 53: Global: Analgesics (Other Pain Types) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 54: Global: Analgesics (Other Pain Types) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 55: Global: Analgesics (Internal Analgesics) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 56: Global: Analgesics (Internal Analgesics) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 57: Global: Analgesics (External Analgesics) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 58: Global: Analgesics (External Analgesics) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 59: North America: Analgesics Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 60: North America: Analgesics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 61: Europe: Analgesics Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 62: Europe: Analgesics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 63: Asia Pacific: Analgesics Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 64: Asia Pacific: Analgesics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 65: Middle East and Africa: Analgesics Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 66: Middle East and Africa: Analgesics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 67: Latin America: Analgesics Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 68: Latin America: Analgesics Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Analgesics Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Analgesics Market Forecast: Breakup by Type (in Million US$), 2019-2024
  • Table 3: Global: Analgesics Market Forecast: Breakup by Drug Class (in Million US$), 2019-2024
  • Table 4: Global: Analgesics Market Forecast: Breakup by ROA (in Million US$), 2019-2024
  • Table 5: Global: Analgesics Market Forecast: Breakup by Pain Type (in Million US$), 2019-2024
  • Table 6: Global: Analgesics Market Forecast: Breakup by Application (in Million US$), 2019-2024
  • Table 7: Global: Analgesics Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 8: Global: Analgesics Market Structure
  • Table 9: Global: Analgesics Market: Key Players
目次
Product Code: SR1018G73_Report

The global analgesics market was worth US$ 44.3 Billion in 2018. Pain currently represents a major global health challenge. Worldwide, it has been estimated that 1 out of every 5 adults suffers from pain and that another 1 in in every 10 adults are diagnosed with chronic pain each year. Analgesics (also known as painkillers or pain relievers) are drugs that are taken to relieve pain. They may be taken to relieve pain that arises from a wide range of conditions, such as appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc. The two major categories of analgesics that are used to treat pain include Opioids and NSAIDs. Majority of the analgesics are taken orally. They may, however, also be taken through other delivery routes such as parenteral, topical, transdermal, rectal, etc.

The global analgesics market is expected to exhibit moderate growth over the next five years. A major factor catalyzing this demand is the strong growth in the geriatric population. In 2017, between 950 Million-1000 Million people were over the age of 60. We expect these numbers to reach 2100 Million by 2050 accounting for 21% of the total global population. The rising older population is expected to increase the incidence of pain arising from a number of chronic and lifestyle diseases. The market for analgesics is also expected to be catalyzed by a strong drug pipeline and high unmet needs. We expect a number of new drugs to be launched in the coming years. Other major factors catalyzing the analgesics market include changing lifestyles, rising prevalence of obesity and overweight, rising prevalence of chronic diseases, etc. Looking forward, the global analgesics market is expected to reach a revenue of US$ 56.8 Billion by 2024, exhibiting a CAGR of around 4% during 2019-2024.

Market Summary:

Based on the drug type, the market has been segmented into prescription analgesics and OTC analgesics. Prescription analgesics currently dominate the market, holding the largest share.

Based on the drug class, the market has been segmented into opioids, NSAIDs and others. Opioids currently represents the biggest segment.

Based on the route of administration, the market has been segmented into oral, parenteral, topical, transdermal and rectal. Currently, oral dominates the market, holding the largest share.

Based on the pain type, the market has been segmented into musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine, obstetrical pain, fibromyalgia, pain due to burns, dental/facial pain, paediatric pain and others. Musculoskeletal pain currently represents the biggest segment.

Based on the application, the market has been segmented into internal analgesics and external analgesics. Internal analgesics currently represent the biggest segment.

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America currently represents the biggest market.

The competitive landscape of the market has also been examined with some of the key players being Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, etc.

Key Questions Answered in This Report:

  • How has the global analgesics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global analgesics industry?
  • What is the breakup of the global analgesics market on the basis of drug type?
  • What is the breakup of the global analgesics market on the basis of drug class?
  • What is the breakup of the global analgesics market on the basis of route of administration?
  • What is the breakup of the global analgesics market on the basis of pain type?
  • What is the breakup of the global analgesics market on the basis of application?
  • What are the various stages in the value chain of the global analgesics market?
  • What are the key driving factors and challenges in the global analgesics market?
  • What is the structure of the global analgesics market and who are the key players?
  • What is the degree of competition in the global analgesics market?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Properties
  • 4.3. Key Industry Trends

5. Global Analgesics Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Type
  • 5.4. Market Breakup by Drug Class
  • 5.5. Market Breakup by ROA
  • 5.6. Market Breakup by Pain Type
  • 5.7. Market Breakup by Application
  • 5.8. Market Breakup by Region
  • 5.9. Market Forecast

6. Market Breakup by Type

  • 6.1. Prescription Analgesics
    • 6.1.1. Market Trends
    • 6.1.2. Market Forecast
  • 6.2. OTC Analgesics
    • 6.2.1. Market Trends
    • 6.2.2. Market Forecast

7. Market Breakup by Drug Class

  • 7.1. Opioids
    • 7.1.1. Market Trends
    • 7.1.2. Market Forecast
  • 7.2. NSAID
    • 7.2.1. Market Trends
    • 7.2.2. Market Forecast
  • 7.3. Others
    • 7.3.1. Market Trends
    • 7.3.2. Market Forecast

8. Market Breakup by ROA

  • 8.1. Oral
    • 8.1.1. Market Trends
    • 8.1.2. Market Forecast
  • 8.2. Parenteral
    • 8.2.1. Market Trends
    • 8.2.2. Market Forecast
  • 8.3. Topical
    • 8.3.1. Market Trends
    • 8.3.2. Market Forecast
  • 8.4. Transdermal
    • 8.4.1. Market Trends
    • 8.4.2. Market Forecast
  • 8.5. Rectal
    • 8.5.1. Market Trends
    • 8.5.2. Market Forecast

9. Market Breakup by Pain Type

  • 9.1. Musculoskeletal Pain
    • 9.1.1. Market Trends
    • 9.1.2. Market Forecast
  • 9.2. Surgical and Trauma Pain
    • 9.2.1. Market Trends
    • 9.2.2. Market Forecast
  • 9.3. Cancer Pain
    • 9.3.1. Market Trends
    • 9.3.2. Market Forecast
  • 9.4. Neuropathic Pain
    • 9.4.1. Market Trends
    • 9.4.2. Market Forecast
  • 9.5. Migraine
    • 9.5.1. Market Trends
    • 9.5.2. Market Forecast
  • 9.6. Obstetrical Pain
    • 9.6.1. Market Trends
    • 9.6.2. Market Forecast
  • 9.7. Fibromyalgia
    • 9.7.1. Market Trends
    • 9.7.2. Market Forecast
  • 9.8. Pain due to Burns
    • 9.8.1. Market Trends
    • 9.8.2. Market Forecast
  • 9.9. Dental/Facial Pain
    • 9.9.1. Market Trends
    • 9.9.2. Market Forecast
  • 9.10. Pediatric Pain
    • 9.10.1. Market Trends
    • 9.10.2. Market Forecast
  • 9.11. Others
    • 9.11.1. Market Trends
    • 9.11.2. Market Forecast

10. Market Breakup by Application

  • 10.1. Internal Analgesics
    • 10.1.1. Market Trends
    • 10.1.2. Market Forecast
  • 10.2. External Analgesics
    • 10.2.1. Market Trends
    • 10.2.2. Market Forecast

11. Market Breakup by Region

  • 11.1. North America
    • 11.1.1. Market Trends
    • 11.1.2. Market Forecast
  • 11.2. Europe
    • 11.2.1. Market Trends
    • 11.2.2. Market Forecast
  • 11.3. Asia Pacific
    • 11.3.1. Market Trends
    • 11.3.2. Market Forecast
  • 11.4. Middle East and Africa
    • 11.4.1. Market Trends
    • 11.4.2. Market Forecast
  • 11.5. Latin America
    • 11.5.1. Market Trends
    • 11.5.2. Market Forecast

12. Global Analgesics Industry: SWOT Analysis

  • 12.1. Overview
  • 12.2. Strengths
  • 12.3. Weaknesses
  • 12.4. Opportunities
  • 12.5. Threats

13. Global Analgesics Industry: Value Chain Analysis

  • 13.1. Overview
  • 13.2. Research and Development
  • 13.3. Raw Material Procurement
  • 13.4. Manufacturing
  • 13.5. Marketing
  • 13.6. Distribution
  • 13.7. End-Use

14. Global Analgesics Industry: Porters Five Forces Analysis

  • 14.1. Overview
  • 14.2. Bargaining Power of Buyers
  • 14.3. Bargaining Power of Suppliers
  • 14.4. Degree of Competition
  • 14.5. Threat of New Entrants
  • 14.6. Threat of Substitutes

15. Global Analgesics Industry: Price Analysis

  • 15.1. Price Indicators
  • 15.2. Price Structure
  • 15.3. Margin Analysis

16. Competitive Landscape

  • 16.1. Market Structure
  • 16.2. Key Players
  • 16.3. Profiles of Key Players
    • 16.3.1. Bayer AG
    • 16.3.2. Novartis AG
    • 16.3.3. GlaxoSmithKline PLC
    • 16.3.4. Pfizer Inc.
    • 16.3.5. Johnson & Johnson
    • 16.3.6. Reckitt Benckiser (RB)
    • 16.3.7. Endo Pharmaceuticals
    • 16.3.8. Bristol-Myers Squibb
    • 16.3.9. Eli Lilly and Company
    • 16.3.10. Sanofi